Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: A single-institution experience using aggressive multimodal therapy

Thyroid

Volumn 21, Issue 1, 2011, Pages 25-30

  Foote, Robert L ^a,b   Molina, Julian R ^a,b   Kasperbauer, Jan L ^a,b   Lloyd, Ricardo V ^a,b   McIver, Bryan ^a,b   Morris, John C ^a,b   Grant, Clive S ^a,b   Thompson, Geoffrey B ^a,b   Richards, Melanie L ^a,b   Hay, Ian D ^a,b   Smallridge, Robert C ^a,b   Bible, Keith C ^a,b  

^a MAYO CLINIC CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; DOXORUBICIN; RADIOSENSITIZING AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PALLIATIVE THERAPY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; THYROID CARCINOMA; TREATMENT OUTCOME;

EID: 78651291649     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0220     Document Type: Article

References (29)

1. Smallridge RC 2010 Anaplastic thyroid carcinoma: patho-genesis and emerging therapies. Clin Oncol (R Coll Radiol) 22:486-497.
2. McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, van Heerden JA, Goellner JR 2001 Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 130:1028-1034.
3. Nutting CM, Convery DJ, Cosgrove VP, Rowbotton C, Vini L, Harmer C, Dearnaley DP, Webb S 2001 Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 60:173-180.
4. Urbano TG, Clark CH, Hansen VN, Adams EJ, Miles EA, Mc Nair H, Bidmead AM, Warrington J, Dearnaley DP, Harmer C, Harrington KJ, Nutting CM 2007 Intensity modulated radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. Radiother Oncol 85:58-63.
5. Rosenbluth BD, Serrano V, Happersett L, Shaha AR, Tuttle RM, Narayana A, Wolden SL, Rosenzweig KE, Chong LM, Lee Ny 2005 Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys 63:1419-1426.
6. Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Evans DB, Clayman G, Sherman SI, Garden AS 2009 Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with con-formal treatment. Int J Radiat Oncol Biol Phys 74:1083-1091.
7. Poster DS, Bruno S, Penta J, Pina K, Catane R 1981 Current status of chemotherapy in the treatment of advanced carcinoma of the thyroid gland. Cancer Clin Trials 4:301-307.
8. Teicher BA, Lazo JS, Sartorelli AC 1981 Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41:73-81.
9. Durand RE 1976 Adriamycin: a possible indirect radio-sensitizer of hypoxic tumor cells. Radiology 19:217-222.
10. Kim JH, Leeper RD 1983 Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy. A new approach. Cancer 52:954-957.
11. Kim JH, Leeper RD 1983 Combination Adriamycin and radiation therapy for locally advanced carcinoma of the thyroid gland. Int J Radiat Oncol Biol Phys 9:565-567.
12. Kim JH, Leeper RD 1987 Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 60:2372-2375.
13. Tennvall J, Tallroth E, El Hassan A, Lundell G, Akerman B, Biörklund A, Blombren H, Löwhagen T, Wallin G 1990 Anaplastic thyroid carcinoma. Doxorubicin, hyperfrac-tionated radiotherapy and surgery. Acta Oncologica 29: 1025-1028.
14. Tennvall J, Lundell G, Hallquist A, Wahlberg P, Wallin G, Tibblin S 1994 Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Cancer 74:1348-1354.
15. Tennvall J, Lundell G, Wahlberg P, Bergenfelz A, Grimelius L, Akerman M, Hjelm Skog A-L, Wallin G 2002 Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 86:1848-1853.
16. Ain KB, Egorin MJ, DeSimone PA 2000 Treatment of ana-plastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 10:587-594.
17. Budman DR, Calabro A 2002 In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines. Breast Cancer Res Treat 74:41-46.
18. Sledge GW Jr 1995 Doxorubicin/paclitaxel combination chemotherapy for metastatic breast cancer: the Eastern Cooperative Oncology Group experience. Semin Oncol 22(5 Suppl 12):123-125.
19. Sprano JA, O'Neill A, Schaefer PL, Falkson CI, Wood WC 2000 Phase II trial of doxorubicin and docetaxel plus GCSF in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196. J Clin Oncol 18:2369-2377.
20. Chen J, Tward JD, Shrieve DC, Hitchcock YJ 2008 Surgery and radiotherapy improves survival in patients with ana-plastic thyroid carcinoma. Am J Clin Oncol 31:460-464.
21. Swaak-Kragten AT, de Wilt JH, Schmitz PI, Bontenbal M, Levendag PC 2009 Multimodality treatment for anaplastic thyroid carcinoma-Treatment outcome in 75 patients. Radiother Oncol 92:100-104.
22. Haigh PI, Ituarte PHG, Wu HS, Treseler PA, Posner MC, Quivey JM, Duh QY, Clark OH 2001 Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91:2335-2342.
23. Tan RK, Finley RK, Driscoll D, Bakamijian V, Hicks WL Jr, Shedd DP 1995 Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 17:41-48.
24. Pudney D, Lau H, Ruether JD, Falck V 2007 Clinical experience of the multimodality management of anaplastic thyroid cancer and literature review. Thyroid 17:1243-1250.
25. Higashiyama T, Ito Y, Hirokawa M, Fukushima M, Uruno T, Miya A, Matsuzuka F, Miyauchi A 2010 Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid 20:7-14.
26. Mitchell G, Huddart R, Harmer C 1999 Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol 50:33-38.
27. De Crevoisier R, Baudin E, Bachelot A, Leboulleux S, Tra-vagli JP, Caillou B, Schlumberger M 2004 Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys 60:1137-1143.
28. Wang Y, Tsang R, Asa S, Dickson B, Arenovich T, Brierley J 2006 Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once-and twice-daily frac-tionation regimens. Cancer 107:1786-1792.
29. Dandekar P, Harmer C, Barbachano Y, Rhys-Evans P, Harrington K, Nutting C, Newbold K 2009 Hyperfractionated accelerated radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis. Int J Radiat Oncol Biol Phys 74:518-521.